新西兰 - 英文 - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - cefaclor monohydrate 262.3mg equivalent to cefaclor 250 mg; cefaclor monohydrate 262.3mg equivalent to cefaclor 250 mg - capsule - 250 mg - active: cefaclor monohydrate 262.3mg equivalent to cefaclor 250 mg excipient: croscarmellose sodium dimeticone gelatin iron oxide red magnesium stearate titanium dioxide active: cefaclor monohydrate 262.3mg equivalent to cefaclor 250 mg excipient: croscarmellose sodium dimeticone gelatin iron oxide red magnesium stearate titanium dioxide

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - cefaclor monohydrate 524.7mg equivalent to cefaclor 500 mg - capsule - 500 mg - active: cefaclor monohydrate 524.7mg equivalent to cefaclor 500 mg excipient: croscarmellose sodium dimeticone gelatin iron oxide red magnesium stearate titanium dioxide

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

boucher & muir (new zealand) limited t/a bnm group - clindamycin hydrochloride 177.515mg equivalent to 150 mg clindamycin - capsule - 150 mg - active: clindamycin hydrochloride 177.515mg equivalent to 150 mg clindamycin excipient: erythrosine gelatin indigo carmine lactose monohydrate magnesium stearate maize starch opacode white s-1-18086 purified talc titanium dioxide - upper respiratory infections including tonsillitis, pharyngitis, sinusitis, otitis media and scarlet fever. lower respiratory infections including bronchitis, pneumonia, empyema and lung abscess.

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

multichem nz limited - iron polymaltose 50 mg/ml (318mg iron polymaltose equivalent to 100mg iron iii) - solution for injection - 50 mg/ml - active: iron polymaltose 50 mg/ml (318mg iron polymaltose equivalent to 100mg iron iii) excipient: hydrochloric acid sodium hydroxide water for injection

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

viatris limited - fluoxetine hydrochloride 22.36mg equivalent to fluoxetine 20 mg;   - capsule - 20 mg - active: fluoxetine hydrochloride 22.36mg equivalent to fluoxetine 20 mg   excipient: acid yellow 17 brilliant blue fcf colloidal silicon dioxide erythrosine gelatin indigo carmine lactose monohydrate magnesium stearate maize starch purified talc sodium laurilsulfate titanium dioxide   water - - depression and its associated anxiety

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

viatris limited - fluoxetine hydrochloride 22.36mg equivalent to fluoxetine 20 mg;   - dispersible tablet - 20 mg - active: fluoxetine hydrochloride 22.36mg equivalent to fluoxetine 20 mg   excipient: colloidal silicon dioxide crospovidone magnesium stearate maize starch mentha x piperita microcrystalline cellulose saccharin sodium - in adults 18 years of age and over: - depression and its associated anxiety - bulimia nervosa - obsessive-compulsive disorder - premenstrual dysphoric disorder - a severe form of pms diagnosis of pmdd: the essential features of pmdd are clear and established cyclicity of symptom (occurring during the last week of the luteal phase in most menstrual cycles) such as depressed mood, anxiety, affective lability, and physical symptoms such as breast tenderness or swelling, headaches, joint or muscle pain, bloating, and weight gain. pmdd is a severe clinical entity and is distinguished from the broader premenstrual syndrome by the intensity of its symptoms (particularly mood symptoms) and the extent to which it interferes with social and/or occupational function.

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - midazolam maleate 20.8mg equivalent to 15 mg midazolam - tablet - 15 mg - active: midazolam maleate 20.8mg equivalent to 15 mg midazolam excipient: lactose monohydrate magnesium stearate maize starch microcrystalline cellulose

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - midazolam maleate 10.2mg equivalent to 7.5 mg midazolam;   - tablet - 7.5 mg - active: midazolam maleate 10.2mg equivalent to 7.5 mg midazolam   excipient: hypromellose lactose magnesium stearate microcrystalline cellulose purified talc starch titanium dioxide - short-term treatment of insomnia. benzodiazepines are only indicated when the disorder is severe, disabling or subjecting the individual to extreme distress.

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

bayer new zealand limited - sorafenib tosilate 274mg equivalent to sorafenib 200 mg; sorafenib tosilate 274mg equivalent to sorafenib 200 mg - film coated tablet - 200 mg - active: sorafenib tosilate 274mg equivalent to sorafenib 200 mg excipient: croscarmellose sodium hypromellose   iron oxide red macrogol 3350 magnesium stearate microcrystalline cellulose sodium laurilsulfate titanium dioxide active: sorafenib tosilate 274mg equivalent to sorafenib 200 mg excipient: croscarmellose sodium hypromellose   iron oxide red macrogol 3350 magnesium stearate microcrystalline cellulose sodium laurilsulfate titanium dioxide - · nexavar is indicated for the treatment of patients with advanced renal cell carcinoma (rcc).

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - dexmedetomidine hydrochloride 118 µg/ml equivalent to dexmedetomidine 100 µg/ml;   - concentrate for infusion - 100 mcg/ml - active: dexmedetomidine hydrochloride 118 µg/ml equivalent to dexmedetomidine 100 µg/ml   excipient: sodium chloride water for injection - for sedation of initially intubated patients during treatment in an intensive care setting. the use of precedex by continuous intubation in these patents should not exceed 24 hours. for sedation of non-intubated patients prior to and/or during surgical and other procedures.